High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult patients with respiratory tract infections Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010
Antimicrobial resistance genotype trends and association with host clinical characteristics in respiratory isolates of haemophilus influenzae Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Increasing incidence of fluoroquinolone resistant tuberculosis in Bombay Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005
Prevalence of erythromycin resistance in lower airway bacterial isolates from patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005
Rapid diagnosis of bacterial co-infection and antimicrobial resistance in patients with SARS-Cov-2 infection Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021
Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020
Long-term, low-dose azithromycin treatment reduces the prevalence of staphylococcus aureus , but selects for macrolide resistance in Danish CF-patients Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003
Infective agents and their antibiotic susceptibility in patients with respiratory infections Source: Eur Respir J 2005; 26: Suppl. 49, 639s Year: 2005
Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey Source: Eur Respir J, 51 (3) 1702571; 10.1183/13993003.02571-2017 Year: 2018
Antibiotic susceptibility patterns of respiratory strains of pseudomonas species in a Turkish university hospital Source: Eur Respir J 2003; 22: Suppl. 45, 514s Year: 2003
Prevalence and antibiotic susceptibility of pathogens from analysis of respiratory samples Source: Eur Respir J 2007; 30: Suppl. 51, 405s Year: 2007
Evaluation the drug susceptibility testing and the prevalence of resistance to antituberculosis drugs in a chronic department Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Treatment of resistant tuberculosis in patients having isolates resistant to multiple antituberculosis drugs Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Frequency of antibiotic resistance and outcomes in severe community acquired pneumonia due to Streptococcus pneumoniae Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
The prevalence of drug resistance tuberculosis in previously treated patients Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis Year: 2008
The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006
Antibiotic resistance in pulmonary infections: mechanisms and epidemiology Source: Eur Respir Monogr 2017; 75: 21-43 Year: 2017
Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance Source: Eur Respir J, 50 (1) 1700598; 10.1183/13993003.00598-2017 Year: 2017
Surveillance of multi-drug resistance and phenotypes of Acinetobacter baumannii isolates producing extended-spectrum-beta-lactamases (ESBLs) from hospital acquired pneumonia patients in west China Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009